Live Breaking News & Updates on Santhera Pharmaceuticals

Stay updated with breaking news from Santhera pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Santhera Publishes Agenda for its Annual General Meeting

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at https://www.santhera.com/share-bondholder-me ....

Pratteln , Switzerland-general , Switzerland , United-kingdom , United-states , America , Swiss , Eva-kalias , European-medicines-agency , Members-of-the-compensation-committee , Santhera-pharmaceuticals , Regulatory-agency

Santhera Pharmaceuticals Holding AG: Santhera Publishes Annual Report 2023

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 - Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2023 with fully audited results ....

Switzerland , Pratteln , Switzerland-general , Eva-kalias , Head-investor-relations-communications , Santhera-pharmaceuticals-holding , Santhera-pharmaceuticals , Annual-report , General-meeting , Head-investor-relations , Ihr-portfolio ,

Santhera Publishes Annual Report 2023

Santhera Publishes Annual Report 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Pratteln , Switzerland-general , Switzerland , United-states , America , Swiss , Eva-kalias , Regulatory-agency , America-to-catalyst-pharmaceuticals-inc , Santhera-pharmaceuticals-holding , Santhera-pharmaceuticals

Research and Markets: Europe Constrained Peptide Drugs Market Analysis 2024-2040: Innovative Pipelines Propel Growth, Strong R&D Focus and Regulatory Framework Enhance Potential

The "Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040" report has been added to ResearchAndMarkets.com's offering. The market size is anticipated to be $0.06 billion in 2026 ....

Spain , Germany , Italy , France , Zealand-pharma , Laura-wood , Biosynth-pepscan , Development-of-constrained-peptides-as-drugs , Office-hours-call , Santhera-pharmaceuticals , Company-profiles , Research-scope